Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Fairway Medical Technologies Inc.

BioPhotonics
Dec 2006
Fairway Medical Technologies Inc. of Houston has received $3.8 million in federal funding to conduct Phase II research on optoacoustic breast and prostate cancer diagnostic methods. The NIH’s National Cancer Institute has awarded the company $2.7 million to develop its laser-ultrasound-nanotechnology system for animal tests and a $1.1 million Small Business Innovation Research grant for the development of a commercial prostate cancer early-detection system. The laser-based technology is used with gold nanorods bound to antibodies to allow higher contrast and definition. It has the potential to detect tumors as small as 2 mm and can differentiate between benign and malignant tumors.

Seno Medical Instruments of San Antonio has purchased Fairway Medical’s optoacoustic technology and will introduce it as a real-time breast cancer detection and diagnosis method. The company will help fund the system’s initial commercialization steps.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!